Science Explorer Interactive view Map
Company · Richmond · Canada

iProgen Biotech (Canada)

iprogen.comROR OpenAlex
Research works
3
▼ 34% vs 2013–17
Citations
16
5.5 per fractional work
Top-10% rate
6.5%
record average 16.5%
Open access
14%
world 28%

Not ranked overall: iProgen Biotech (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does iProgen Biotech (Canada) publish most on?

By volume in 2022–2025: RNA modifications and cancer, RNA Research and Splicing, Molecular Biology Techniques and Applications and Pancreatic and Hepatic Oncology Research.

RNA modifications and ca…0RNA modifications and cancer: 0 fractional worksRNA Research and Splicing0RNA Research and Splicing: 0 fractional worksMolecular Biology Techni…0Molecular Biology Techniques and Applications: 0 fractional works
Molecular Biology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA modifications and cancer Molecular Biology 0 works
  2. 2 RNA Research and Splicing Molecular Biology 0 works
  3. 3 Molecular Biology Techniques and Applications Molecular Biology 0 works
  4. 4 Pancreatic and Hepatic Oncology Research Oncology 0 works
  5. 5 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  6. 6 Caveolin-1 and cellular processes Cell Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available13.8%not open86.2%

World: 28% of research is openly available.

with international co-authors2.3%domestic only97.7%

World: 19% is written across borders.

Other research institutions in Richmond

All research institutions in Richmond

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.